Sensitivity and Specificity of Selected Biomarkers and Their Combinations in the Diagnosis of Ovarian Cancer
Diagnostics · 30.04.2024 · 14 (9) · 949
DOI: 10.3390/diagnostics14090949 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 30.04.2024. Verfasst von Aleksandra Englisz und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Doctoral School, Medical University of Silesia, 40-055 Katowice, Poland. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia in Katowice.
Abstract (Originalsprache)
One of the greatest challenges in modern gynecological oncology is ovarian cancer. Despite the numerous studies currently being conducted, it is still sometimes detected at late clinical stages, where the prognosis is unfavorable. One significant contributing factor is the absence of sensitive and specific parameters that could aid in early diagnosis. An ideal screening test, in view of the low incidence of ovarian cancer, should have a sensitivity of greater than 75% and a specificity of at least 99.6%. To enhance sensitivity and specificity, diagnostic panels are being created by combining individual markers. The drive to develop better screening tests for ovarian cancer focuses on modern diagnostic methods based on molecular testing, which in turn aims to find increasingly effective biomarkers. Currently, researchers’ efforts are focused on the search for a complementary parameter to those most commonly used that would satisfactorily enhance the sensitivity and specificity of assays. Several biomarkers, including microRNA molecules, autoantibodies, cDNA, adipocytokines, and galectins, are currently being investigated by researchers. This article reviews recent studies comparing the sensitivity and specificity of selected parameters used alone and in combination to increase detection of ovarian cancer at an early stage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Doctoral School, Medical University of Silesia, 40-055 Katowice, Poland.
- Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.
ORCID-Profile: Marta Smycz-Kubańska, Aleksandra Mielczarek-Palacz
Förderung
- Medical University of Silesia in Katowice
Zitieren
APA
Englisz, A., Smycz-Kubańska, M., & Mielczarek-Palacz, A. (2024). Sensitivity and Specificity of Selected Biomarkers and Their Combinations in the Diagnosis of Ovarian Cancer. Diagnostics, 14(9), 949. https://doi.org/10.3390/diagnostics14090949
Vancouver
Englisz A, Smycz-Kubańska M, Mielczarek-Palacz A. Sensitivity and Specificity of Selected Biomarkers and Their Combinations in the Diagnosis of Ovarian Cancer. Diagnostics. 2024;14(9):949. doi:10.3390/diagnostics14090949
BibTeX
@article{Englisz2024,
author = {Englisz, Aleksandra and Smycz-Kubańska, Marta and Mielczarek-Palacz, Aleksandra},
title = {Sensitivity and Specificity of Selected Biomarkers and Their Combinations in the Diagnosis of Ovarian Cancer},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {9},
pages = {949},
doi = {10.3390/diagnostics14090949}
}
EUVIMED